Trial will test otilimab as a treatment for severe lung disease
UC Davis Health has been selected as a site for a new clinical trial (OSCAR) to test otilimab as a potential treatment for severe pulmonary COVID-19-related disease.
Otilimab, a human monoclonal antibody, was under investigation as a treatment for rheumatoid arthritis. Now, the OSCAR clinical trial will evaluate the efficacy and safety of a single infusion of otilimab in treating severe lung inflammation in COVID-19 patients.
Clinicians, researchers, patients and the general public are invited to submit questions that could be answered by COVID-19 patient medical record data from 200+ hospitals
As the COVID-19 pandemic continues, there is an urgent need to determine who is at greatest risk for severe disease, better understand how the disease and treatments evolve, and predict the need for resources. But to get there, researchers and clinicians need more data about what patients have experienced so far, and what factors are associated with different patient outcomes.
Alumna Is Studying Canines' Abilities to Identify, Respond to Virus Metabolites
Jenna Gadberry ’03 is using her extensive background in chemical and biological defense to answer the question: Could dogs detect COVID-19?
Gadberry, a researcher with the U.S. Army’s Combat Capabilities Development Command Chemical Biological Center, has studied canine detection for military explosives. When the question about COVID-19 arose, her team partnered with the University of Pennsylvania School of Veterinary Medicine Working Dog Center.
Worried Doctors Stress Flu Shots More Important Than Ever
wo things are certain about the flu season knocking at our door during the COVID-19 pandemic: First, it’s never been more important to get your flu shot. Next, no one knows how this influenza season will play out.
The uncertainty covers almost every aspect of the flu — how dangerous this year’s strain will be, how contagious it will be, how the flu will interact with COVID-19, and what might happen if a person gets both the flu and COVID-19.
Valuable coronavirus treatment info was exchanged early in the outbreak
(SACRAMENTO) —
In the first weeks of the COVID-19 pandemic, health care providers and academic medical centers worldwide were scrambling to gather information about treatments for the very novel disease.
Funding will help the UC Davis Clinical and Translational Science Center and the Center for Reducing Health Disparities reach underserved population during pandemic
(SACRAMENTO)
UC Davis and two other universities have been awarded a $2.3 million grant from the National Institutes of Health to train and empower community health workers in research best practices, which could help reduce disparities related to the ongoing COVID-19 pandemic.
Research is expanding what we know about the novel coronavirus and how to stay safe
In early August, a handful of national media stories reported on a study from Duke University about face masks and COVID-19. The stories appeared to report something new, but they got it wrong.
